Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
+281K
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
+$7.24M
-
Put/Call ratio
-
0.4
-
Number of buys
-
114
-
Number of sells
-
-93
-
Price
-
$17.73
Significant Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2019
269 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q4 2019.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (14M shares), BlackRock Inc. (12.1M shares), Bellevue Group AG (8.04M shares), Third Security, LLC (7.05M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (6.33M shares), Artisan Partners Limited Partnership (5.26M shares), Invesco Ltd. (4.73M shares), JPMORGAN CHASE & CO (4.6M shares), STATE STREET CORP (4.49M shares), and SNYDER CAPITAL MANAGEMENT L P (3.5M shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.